Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Malignant Neoplasms of Independent (Primary) Multiple Sites 1Esophageal Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Electrocardiography, Ambulatory × Clear all
NCT04835987 2023-11-24

PROSNACO

Centre Hospitalier Universitaire de Saint Etienne

Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT03177681 2023-03-27

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

M.D. Anderson Cancer Center

Phase NA Withdrawn
Other neoplasm

Malignant Neoplasms of Independent (Primary) Multiple Sites

Data powered by HemOnc (CC BY 4.0) Colophon âš¡